Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Cara Therapeutics Announces 1-for-12 Reverse Stock Split Of Its Outstanding Shares Of Common Stock And Reduction In Total Number Of Authorized Shares From 200M To 16.66M, Which Will Be Effective On December 30

Author: Benzinga Newsdesk | December 27, 2024 08:06am

Posted In: CARA